Potency of sphaerimicin analogs (IMAGE)
Caption
The sphaerimicin analogs (SPMs) inhibit the activity of MraY, and hence the replication of bacteria, with different degrees of effectiveness. The potency of the analog increases as the IC50 decreases (Takeshi Nakaya, et al. Nature Communications. December 20, 2022).
Credit
(Takeshi Nakaya, et al. Nature Communications. December 20, 2022)
Usage Restrictions
This image is copyrighted, but may be used to report on this press release if credited as instructed.
License
Licensed content